Investors

Genomic Vision is a publicly-traded company on the Euronext regulated market in Paris

 

 

Regulated Information

Financial Reports

Click here to access the French documentation “Suivi du programme d’OCABSA avec Winance“

Click here to access the French documentation “Suivi du programme d’OCABSA avec Winance – 31/12/2020”

Click here to access the French documentation “Nombre total d’actions et de droits de vote – 31/12/2020”

Click here to access the French documentation “Rapport Financier Semestriel du 30 Juin 2020“

Click here to access the French documentation  “Rapport Financier Annuel 2019“

Status updated – July 2020

First Semester Financial Report 2019 (French)

Reference document 2018 (French) part 1 excl section 20.4 Financial statements French GAAP p234-266

Reference document 2018 (French) part 2 section 20.4 Financial statements French GAAP p234-266

First Semester Financial Report 2018 (French)

Annual Financial Report 2017 (French)

First Semester Financial Report 2017 (French)

Reference document 2016 (French)

First Semester Financial Report 2016 (French)

Annual Financial Report 2015 (French)

First Semester Financial Report 2015 (French)

Annual Financial Report 2014 (French)

First Semester Financial Report 2014 (French)

 

Monthly Statement

> Information on December 31, 2019 (French)

 

Articles of association (French)

ABSA Prospectus (French)

> ABSA Prospectus – note d’opération (French)

 

IPO Prospectus (French)

Half-yearly report on the liquidity contract (French)

Rules of procedure of the supervisory board (French)

Press Releases

 

frise

 

genomic_web_visuels_footer_COMPANY